These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6139748)

  • 1. [Long-term treatment following myocardial infarction. Pharmaco-epidemiological study of drug prescription].
    Weiss B; Donat K; Ziegler WJ
    MMW Munch Med Wochenschr; 1983 Oct; 125(42):921-4. PubMed ID: 6139748
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical pharmacology and indications for treatment with calcium antagonists].
    Bölter C
    Z Arztl Fortbild (Jena); 1984; 78(1):1-4. PubMed ID: 6143456
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug prescription in myocardial postinfarction: results of the EPPI (étude de prescription postinfarctus). A French cooperative study].
    Boissel JP; Némoz C; Gillet J; Salewski B; Diaz N
    Arch Mal Coeur Vaiss; 1990 Nov; 83(12):1777-82. PubMed ID: 1980055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term management after myocardial infarction (Part 2.): Medical interventions].
    Czuriga I
    Orv Hetil; 2004 Dec; 145(52):2629-32. PubMed ID: 15724699
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug therapy of coronary heart disease--are therapeutic guidelines being paid attention to?].
    Böger GI; Hoopmann M; Busse R; Budinger M; Welte T; Böger RH
    Z Kardiol; 2003 Jun; 92(6):466-75. PubMed ID: 12819995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug prescription in the postinfarction period; results of the EPPI II (Study of Postinfarct Prescription). A French cooperative study].
    Boissel JP; Némoz C; Leizorovicz A; Gillet J
    Arch Mal Coeur Vaiss; 1995 Sep; 88(9):1261-6. PubMed ID: 8526704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of other drugs apart from antithrombotic and antiplatelet agents for the treatment of non-ST-elevation acute coronary syndromes].
    Birdane A; Ata N
    Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():30-4. PubMed ID: 16613773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug therapy under physical conditioning and during phase III rehabilitation in patients following acute myocardial infarct].
    Dahn G; Kothe K
    Z Gesamte Inn Med; 1990 Jul; 45(14):411-3. PubMed ID: 1981410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antianginal and antiadrenergic therapy in acute coronary syndrome].
    Raos V; Bergovec M
    Acta Med Croatica; 2004; 58(2):123-7. PubMed ID: 15208797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Attitude of patients after myocardial infarction to long-term therapy with beta blockers].
    Shutemova EA; Zhukova AI; Lebedeva LV
    Klin Med (Mosk); 2001; 79(2):63-5. PubMed ID: 11419093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the patterns of drug prescription for acute myocardial infarct. Comparison of 2 periods].
    Prieto JC; Corbalán R; Nazza C; Chávez E; Lanas F; Bartolucci J; Cumsille F;
    Rev Med Chil; 2001 May; 129(5):481-8. PubMed ID: 11464528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns.
    Rywik TM; Rywik SL; Korewicki J; Broda G; Sarnecka A; Drewla J
    Int J Cardiol; 2004 Jun; 95(2-3):177-84. PubMed ID: 15193817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic thrombolytic therapy of myocardial infarct using streptokinase combined with nitroglycerin and beta blockers].
    Ukolov VM; Iakovlev VA; Malygin VN; Severin SI; Semenov AV
    Sov Med; 1990; (4):50-4. PubMed ID: 1973847
    [No Abstract]   [Full Text] [Related]  

  • 15. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 4. Results of a summarizing evaluation with factor analysis and multiple regression analysis].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1879-93. PubMed ID: 4155951
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of medical therapy on long-term survival in ischemic heart disease].
    Caruzzo C; Sechi A; Monti C; Campagna G; Spinnler MT
    Minerva Cardioangiol; 1984 Dec; 32(12):887-93. PubMed ID: 6152332
    [No Abstract]   [Full Text] [Related]  

  • 17. Treating hypertension. Are the right drugs given to the right patients?
    Beaulieu MD; Dufresne L; LeBlanc D
    Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differences in pharmacologic treatment after acute myocardial infarction. The role of treatment effectiveness].
    Bobbio M; Imazio M; Tidu M; Presbitero P; Trinchero R; Brusca A
    G Ital Cardiol; 1997 Jun; 27(6):549-56. PubMed ID: 9280724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockers and depression after myocardial infarction: a multicenter prospective study.
    van Melle JP; Verbeek DE; van den Berg MP; Ormel J; van der Linde MR; de Jonge P
    J Am Coll Cardiol; 2006 Dec; 48(11):2209-14. PubMed ID: 17161247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs and the heart four years on.
    Opie LH
    Lancet; 1984 Mar; 1(8375):496-501. PubMed ID: 6142216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.